Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers: Use This Drop Before Its Too Late

…

Hims & Hers Short Interest Nears All-Time High, Buy The Dip?

Hims & Hers stock is falling well off its 52-week highs, as bears lean on the CEOs scheduled sale that…

Menopause Care Expansion Could Be a Game Changer for Hims & Hers Health (HIMS)

Earlier this month, Hims & Hers Health, Inc. launched a new women’s health specialty offering personalized, affordable treatment plans for…

Telehealth Stock Could Rebound Off Long-Term Trendline

Hims & Hers Health (HIMS) stock recently staged a steep pullback, but could be on its way to reocoup some…

Hims & Hers Stock: Theres Opportunity In This Crash (Upgrade) (NYSE:HIMS)

Hims & Hers stock is a "Buy" after a 30% dip. Learn more about HIMS stocks growth targets, valuation, and…

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory

We came across a bullish thesis on Hims & Hers Health, Inc. on Business Ontology’s Substack by Lorenzo Bastianelli. In…

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory

We came across a?bullish thesis?on Hims & Hers Health, Inc. on Business Ontology’s Substack by Lorenzo Bastianelli. In this article, we…

Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today

In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $47.46, marking a -3.85% move from the…

Should You Rethink Hims After Volatile Moves and New Product Launches in 2025?

If you’ve been watching Hims & Hers Health lately and wondering what to do next, you’re not alone. The past…

Hims & Hers Health Stock (HIMS) Opinions on Menopause Care Launch

Menopause Care Launch: Recent discussions on X about Hims & Hers Health (HIMS) have been ignited by the company’s launch…

Hims & Hers Advances AI-Powered Personalized Digital Healthcare

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is intensifying its use of artificial intelligence (AI),…

Could Hims & Hers Healths (HIMS) Menopause Expansion Reveal a New Competitive Edge in Womens Care?

Earlier this month, Hims & Hers Health announced the launch of a new specialty in womens health, expanding its Hers…

The Problems We’re Solving in Healthcare

Since joining Hims & Hers earlier this year, I’ve spent a lot of time thinking about why getting healthcare still…

After financial troubles, Grail raises $325M from Hims and others

Grail raises $325M from investors including Hims & Hers, preparing for FDA submission of multi-cancer blood test. Company now has…

Hims & Hers (HIMS) Faces Margin Concerns Amid Growth Plans

Key Takeaways: Hims & Hers (HIMS) faces concerns over profit margins despite growth potential. …

CEO Andrew Dudum Is Ditching Hims & Hers Stock. Should You?

Insider selling tests investor confidence as Hims & Hers faces valuation pressure and shifting GLP-1 momentum.…

CEO Andrew Dudum Is Ditching Hims & Hers Stock. Should You?

Healthcare and telemedicine stocks have delivered some of the market’s biggest winners in recent years, as investors bet on the…

Hims & Hers rated Sector Weight at KeyBanc (HIMS:NYSE)

Hims & Hers (HIMS) stock slips as KeyBanc launches its coverage with a Sector Weight rating, citing concerns over the…

HIMS Stock Declines Despite Launch of New Specialty in Womens Health

Hims & Hers debuts a new womens health specialty, targeting menopause care with personalized treatment plans.…

HIMS Stock Declines Despite Launch of New Specialty in Womens Health

Hims & Hers Health, Inc. HIMS launched a new specialty in women’s health last week. It offers access to affordable…

Hims & Hers Q3 Preview: Key Metrics I Want To See For Beating 2030 Guidance (HIMS)

Hims & Hers Health, Inc. offers 30% upside to $64 based on management guidance with potential rerating to $353. Learn…

Hims & Hers Aktie: "Disruptiver Gesundheits-Star"

Cleveland (www.aktiencheck.de) - Hims & Hers-Aktienanalyse von KeyBanc Capital Markets:KeyBanc Capital Markets habe die Coverage der Aktie von Hims &…

HIMS: Keybanc Initiates Coverage with Sector Weight Rating

Key Takeaways Keybanc initiates coverage on Hims & Hers Health (HIMS) with a Sector Weight rating. …

Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains Bright (HIMS)

Discover how Hims & Hers Health, Inc. is disrupting the obesity drug market amid regulatory changes. Learn what investors should…

Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains Bright

…

Hims & Hers CFO Okupe sells $662k in shares By Investing.com

Hims & Hers CFO Okupe sells $662k in shares…

Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.9% in the morning session after investors looked past a…

Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know

Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know…

Hims & Hers Health: Roller Coaster Gift (NYSE:HIMS)

Hims & Hers Health launched menopause and low testosterone products in the last month, expanding its addressable market. Read the…

Hims & Hers Health (HIMS): Exploring Valuation Following Major Menopause Treatment Launch

Hims & Hers Health (HIMS) just rolled out personalized treatment plans focused on menopause and perimenopause, signaling an ambitious step…

Hims & Hers Health Faces Stock Turbulence

Hims & Hers Health ( ($HIMS) ) has fallen by -9.04%. Read on to learn why. Hims & Hers Health…

Hims & Hers Health (HIMS): How the Menopause Launch Shapes Valuation and Growth Expectations

Hims & Hers Health (NYSE:HIMS) is making headlines with the rollout of personalized treatment plans for women dealing with menopause…

$11 million insider sale shakes Hims & Hers confidence

Hims & Hers stock plunges 23% toward $50 support as Trumps weight-loss drug pricing comments and $11M CEO share sale…

Should the New Menopause Specialty and CEO Share Sale Prompt a Closer Look at HIMS?

Hims & Hers Health, Inc. recently introduced a new specialty in womens health, offering affordable personalized treatment plans for women…

Hims & Hers CEO sells, analyst calls on Planet Fitness & Deere

Josh Lipton examines some of the top stories on Wall Street as part of Yahoo Finances Market Minute: Hims &…

Why Hims & Hers stock is failing to retain menopause gains and what comes next?

Hims & Hers Health Inc NYSE:HIMS started this week on a positive note after announcing its expansion into menopause-related treatments…

Hims & Hers Health shares plunge 14% - heres what is fueling the fall

Hims stock: Hims & Hers Health shares plunged nearly 13% as investors reacted to CEO Andrew Dudums $11 million stock…

Hims & Hers Stock Nosedives -- CEO Cashes Out $11 Million Stake

Hims & Hers Stock Faces Sharp Drop After Insider Sale Revelation…

Why Hims & Hers Health Shares Are Tumbling

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers Health (HIMS) Stock Tanks 13% after CEO Discloses Stock Sale

Shares of healthcare company Hims Hers Health ($HIMS) tanked around 13% at the time of writing after CEO Andrew…

Hims & Hers Health down 11% after CEO Dudum stock sale disclosure

Hims & Hers Health stock drops 11% after CEO Andrew Dudum sells $11M in shares. Read more here.…

Hims & Hers Health stock falls after Trump promises lower weight loss drug prices By Investing.com

Hims & Hers Health stock falls after Trump promises lower weight loss drug prices…

Hims & Hers Health stock falls after Trump promises lower weight loss drug prices By Investing.com

Hims & Hers Health stock falls after Trump promises lower weight loss drug prices…

Hims & Hers: Navigating Financial Challenges

Hims & Hers Health Inc. stocks have been trading down by -2.4 percent amid market reactions to strategic shifts in…

Here

Hims & Hers Health, Inc. (HIMS) ended the recent trading session at $59.15, demonstrating a -5.75% change from the preceding…

Heres Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market

Hims & Hers Health, Inc. (HIMS) reached $59.15 at the closing of the latest trading day, reflecting a -5.75% change…

Hims & Hers CEO sells stock after menopause expansion announcement

Hims rose more than 15% on Wednesday after the company announced it would expand its offerings before giving back some…

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.8% in the afternoon session after a Bank of America…

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

What Happened? Shares of telehealth company Hims & Hers Health NYSE:HIMS fell 6.8% in the afternoon session after a Bank…